Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
GOT1 Inhibition by Ziprasidone Disrupts Glutamine Metabolism
2026-06-05
The referenced study uncovers ziprasidone as a non-competitive inhibitor of GOT1, leading to metabolic reprogramming and suppressed proliferation in pancreatic ductal adenocarcinoma (PDAC) cells. This work highlights GOT1 as a promising therapeutic target and elucidates mechanisms by which glutamine metabolism sustains tumor growth.
-
Optimizing Cell Lysis with NP-40 Lysis Buffer: Protocols & I
2026-06-05
NP-40 Lysis Buffer enables efficient, non-denaturing protein extraction from diverse biological sources while preserving native protein complexes. Discover workflow enhancements, troubleshooting strategies, and experimental insights that directly support robust immunoprecipitation and neuroinflammation research.
-
Thymoquinone in Cardioprotection: Pathway Modulation and Tra
2026-06-04
Discover the multifaceted action of thymoquinone, a potent small-molecule probe, as a modulator of cardiotoxicity pathways. This article uniquely examines how thymoquinone's mechanism—beyond classic antioxidant roles—enables advanced experimental designs in cardiovascular research.
-
OSMI-1: Precision O-GlcNAc Transferase Inhibition in Ferropt
2026-06-04
Explore how OSMI-1, a leading O-GlcNAc transferase inhibitor, enables unprecedented mechanistic insights into ferroptosis and protein O-GlcNAcylation. This article bridges assay optimization with emerging disease models, offering novel perspectives beyond current literature.
-
Omeprazole (A2845): Technical Guidance for Gastric Acid Rese
2026-06-03
Omeprazole (SKU A2845) is a high-purity H+,K+-ATPase inhibitor for controlled research on gastric acid secretion and antiulcer mechanisms. It is best suited for in vitro and preclinical workflows, not for diagnostic or therapeutic use. Proper handling and protocol adherence are essential to ensure reliable results in gastric acid-related studies.
-
Dietary Arachidonic Acid Enhances Vaccine-Induced Humoral Im
2026-06-03
This study demonstrates that dietary arachidonic acid supplementation significantly accelerates and amplifies the humoral immune response to rabies vaccination in both mice and humans. The mechanistic insight into lymph node enrichment and metabolite-driven B cell activation highlights new strategies for modulating vaccine efficacy and optimizing immune responses.
-
BML-277: A Selective Chk2 Inhibitor for DNA Damage Research
2026-06-02
BML-277 is redefining DNA damage response research with its high potency and selectivity as a Chk2 inhibitor, offering robust tools for radioprotection and genome stability assays. Its ATP-competitive inhibition and nanomolar efficacy enable precise interrogation of checkpoint pathways in cancer and senescence models.
-
Dlin-MC3-DMA: Ionizable Cationic Liposome for RNA Delivery B
2026-06-02
D-Lin-MC3-DMA empowers next-generation lipid nanoparticle workflows by enabling potent, low-toxicity siRNA and mRNA delivery—even in challenging cell types like hyperactivated microglia. This article translates the latest machine learning-guided LNP design and hands-on protocol enhancements into actionable strategies for researchers seeking robust gene silencing, immunomodulation, or vaccine platforms.
-
Nile Red for Lipid Droplet Staining: Protocols & Innovations
2026-06-01
Nile Red (Nile blue oxazone) delivers dual-emission precision for intracellular lipid droplet staining, excelling in both fundamental research and advanced lipid metabolism analysis. This article details robust workflows, key experimental optimizations, and new insights from recent autophagy-lipid studies, positioning APExBIO’s Nile Red as a gold-standard dye for sensitive, reproducible lipid imaging.
-
Luminescent ATP Cell Viability Assay I: Precision in Ferropt
2026-06-01
Explore how the Luminescent ATP Cell Viability Assay Kit I enables ultra-sensitive cell viability measurement using luciferase luminescence detection. This article uniquely analyzes how recent ferroptosis mechanisms inform assay strategy, distinguishing it from existing resources.
-
Dynasore: Benchmark Dynamin GTPase Inhibitor for Endocytosis
2026-05-31
Dynasore is a potent, reversible dynamin GTPase inhibitor widely used in endocytosis research to block vesicle scission processes. With a documented IC50 of ~15 µM against dynamin GTPases, it enables precise dissection of endocytic pathways in cellular and neuronal models. Its use is supported by reproducible, peer-reviewed evidence and comprehensive solubility and storage data.
-
Zolmitriptan: 5-HT1B Receptor Agonist for Migraine Research
2026-05-30
Zolmitriptan is a potent 5-HT1B receptor agonist used in migraine research. Its selectivity, solubility in DMSO and ethanol, and high purity support robust serotonin receptor pharmacology studies. This article details mechanism, benchmarks, and workflow integration for Zolmitriptan.
-
Applied Use of α-Linolenic Acid in Lipid Metabolism Research
2026-05-29
α-Linolenic Acid (ALA) is a pivotal tool for unraveling lipid signaling and metabolism in health and disease. Here, we detail robust protocols, troubleshooting insights, and experimental innovations using ALA, with cross-domain perspectives anchored by recent advances in immune modulation.
-
Risedronate Sodium: FPP Synthase Inhibitor for Bone & Lung M
2026-05-29
Risedronate Sodium is redefining experimental design in bone metabolism and respiratory research as a potent FPP synthase inhibitor. Its advanced workflows, especially via nano-enabled inhaled delivery, offer robust disease modeling and translational leverage in osteoporosis and emphysema studies.
-
Dantrolene Sodium Salt: High-Purity Ryanodine Receptor Antag
2026-05-28
Dantrolene sodium salt is a potent ryanodine receptor antagonist used to modulate intracellular calcium release in disease and genome editing models. Its calmodulin-dependent inhibition, high purity, and reproducible performance make it a standard for research on calcium signaling and DNA repair pathway choice.